Charles W. Newton
Director at Keros Therapeutics, Inc. (KROS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $11K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 20SEC | KROSKeros Therapeutics, Inc. | Sell Plan | 55112,114 held (−4%) | $10.30 | $6K | +3.5% |
| Jun 15SEC | KROSKeros Therapeutics, Inc. | Sell Plan | 55012,665 held (−4%) | $10.04 | $6K | +6.2% |
- Sell
Director Charles W. Newton sold $6K of KROS at $10.30 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Charles W. Newton sold $6K of KROS at $10.04 — pre-scheduled 10b5-1 plan sale.